66 results
Page 3 of 4
D
z2gc yaqqrhx3t8
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
uplu7kcrfkbtwv2za5c
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
g4z6lby
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
3l30pdzvh isu5wi
14 May 21
Quarterly report
4:31pm
10-K
j3yqvg7 ijheb
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
a611q9k9uzo2lxulg
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
bm9gw7c9cx t3kug70rx
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
ba4i4 ykk
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
EX-4.3
pr6w595
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
7e1j9i a0
29 Jan 21
Shelf registration
4:48pm
S-3
o47u3sid 0p7mf22i
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
g14zoo2ycky
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-10.1
67f0xn
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.1
eff xsr2sepy9
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
pm6 5tgtg79n7j339
2 Nov 20
Prospectus supplement
12:00am